Dr Reddy's Laboratories Operating Expenses 2010-2024 | RDY

Dr Reddy's Laboratories annual/quarterly operating expenses history and growth rate from 2010 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Dr Reddy's Laboratories operating expenses for the quarter ending September 30, 2024 were $0.745B, a 21.53% increase year-over-year.
  • Dr Reddy's Laboratories operating expenses for the twelve months ending September 30, 2024 were $2.770B, a 14.3% increase year-over-year.
  • Dr Reddy's Laboratories annual operating expenses for 2024 were $2.538B, a 10.49% increase from 2023.
  • Dr Reddy's Laboratories annual operating expenses for 2023 were $2.297B, a 5.74% decline from 2022.
  • Dr Reddy's Laboratories annual operating expenses for 2022 were $2.437B, a 13.61% increase from 2021.
Dr Reddy's Laboratories Annual Operating Expenses
(Millions of US $)
2024 $2,538
2023 $2,297
2022 $2,437
2021 $2,145
2020 $1,881
2019 $1,923
2018 $1,998
2017 $1,963
2016 $1,888
2015 $1,956
2014 $1,768
2013 $1,778
2012 $1,536
2011 $1,419
2010 $1,340
2009 $79
Dr Reddy's Laboratories Quarterly Operating Expenses
(Millions of US $)
2024-09-30 $745
2024-06-30 $706
2024-03-31 $660
2023-12-31 $659
2023-09-30 $613
2023-06-30 $606
2023-03-31 $579
2022-12-31 $626
2022-09-30 $587
2022-06-30 $506
2022-03-31 $660
2021-12-31 $590
2021-09-30 $614
2021-06-30 $572
2021-03-31 $566
2020-12-31 $563
2020-09-30 $538
2020-06-30 $477
2020-03-31 $346
2019-12-31 $515
2019-09-30 $578
2019-06-30 $442
2019-03-31 $522
2018-12-31 $456
2018-09-30 $471
2018-06-30 $475
2018-03-31 $485
2017-12-31 $512
2017-09-30 $494
2017-06-30 $507
2017-03-31 $553
2016-12-31 $460
2016-09-30 $487
2016-06-30 $462
2016-03-31 $458
2015-12-31 $488
2015-09-30 $472
2015-06-30 $470
2015-03-31 $489
2014-12-31 $495
2014-09-30 $490
2014-06-30 $482
2014-03-31 $492
2013-12-31 $442
2013-09-30 $419
2013-06-30 $415
2013-03-31 $513
2012-12-31 $447
2012-09-30 $431
2012-06-30 $387
2012-03-31 $359
2011-12-31 $380
2011-09-30 $419
2011-06-30 $378
2011-03-31 $414
2010-12-31 $362
2010-09-30 $333
2010-06-30 $310
2010-03-31 $382
2009-12-31 $318
2009-09-30 $328
2009-06-30 $312
2009-03-31 $202
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $11.978B $3.350B
Dr. Reddy's Laboratories Ltd. is an integrated global pharmaceutical company engaged in providing affordable and innovative medicines since 1984. The company markets its products in countries like the U.S., the UK, Germany, India, Russia, Venezuela, Romania and South Africa. Dr. Reddy's operates through three segments: Global Generics comprising unbranded prescription drugs along with over-the-counter drugs. It includes the operations of the company's biologics business. Pharmaceutical Services & Active Ingredients (PSAI) comprising active pharmaceutical ingredients (API) and custom pharmaceutical services. Proprietary Products and Others involving the new chemical entities, the differentiated formulations business and a dermatology specialty business. The company has a strategic partnership with Glaxo to market selected products across emerging markets outside India.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00